Beijing SL Pharmaceutical Co Ltd (002038) — Free Cash Flow Generation Index
Beijing SL Pharmaceutical Co Ltd (002038) has a Free Cash Flow Generation Index of 0.83x as of September 2025. Free cash flow of CN¥55.21 Million represents 1% of operating cash flow (CN¥66.55 Million). Read Beijing SL Pharmaceutical Co Ltd total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Beijing SL Pharmaceutical Co Ltd Free Cash Flow Generation Index (2003–2025)
Historical FCF Generation Index trend for Beijing SL Pharmaceutical Co Ltd across 23 annual periods. Explore Beijing SL Pharmaceutical Co Ltd (002038) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Beijing SL Pharmaceutical Co Ltd (2003–2025)
Year-by-year Free Cash Flow Generation Index for Beijing SL Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 002038 market cap.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.25x | CN¥64.69 Million | CN¥257.66 Million | CN¥192.97 Million | ▲ +146.4% |
| 2024 | -0.54x | CN¥-121.89 Million | CN¥225.49 Million | CN¥347.38 Million | ▼ -202.9% |
| 2023 | 0.53x | CN¥241.84 Million | CN¥460.20 Million | CN¥218.36 Million | ▼ -9.5% |
| 2022 | 0.58x | CN¥226.33 Million | CN¥389.82 Million | CN¥163.49 Million | ▲ +18.5% |
| 2021 | 0.49x | CN¥227.72 Million | CN¥464.63 Million | CN¥236.91 Million | ▲ +27.5% |
| 2020 | 0.38x | CN¥159.89 Million | CN¥415.84 Million | CN¥255.95 Million | ▼ -34.9% |
| 2019 | 0.59x | CN¥393.04 Million | CN¥665.83 Million | CN¥272.78 Million | ▲ +11.1% |
| 2018 | 0.53x | CN¥257.80 Million | CN¥485.17 Million | CN¥227.37 Million | ▲ +33.9% |
| 2017 | 0.40x | CN¥151.08 Million | CN¥380.72 Million | CN¥229.65 Million | ▼ -32.3% |
| 2016 | 0.59x | CN¥232.65 Million | CN¥396.86 Million | CN¥164.21 Million | ▼ -21.1% |
| 2015 | 0.74x | CN¥375.19 Million | CN¥504.87 Million | CN¥129.68 Million | ▲ +10.1% |
| 2014 | 0.68x | CN¥313.99 Million | CN¥465.00 Million | CN¥151.01 Million | ▼ -1.4% |
| 2013 | 0.68x | CN¥237.94 Million | CN¥347.41 Million | CN¥109.48 Million | ▲ +81.1% |
| 2012 | 0.38x | CN¥150.70 Million | CN¥398.60 Million | CN¥247.89 Million | ▼ -44.4% |
| 2011 | 0.68x | CN¥155.54 Million | CN¥228.59 Million | CN¥73.05 Million | ▼ -16.9% |
| 2010 | 0.82x | CN¥195.09 Million | CN¥238.13 Million | CN¥43.04 Million | ▼ -0.7% |
| 2009 | 0.83x | CN¥143.95 Million | CN¥174.41 Million | CN¥30.46 Million | ▼ -6.0% |
| 2008 | 0.88x | CN¥170.71 Million | CN¥194.32 Million | CN¥23.61 Million | ▲ +25.7% |
| 2007 | 0.70x | CN¥61.75 Million | CN¥88.36 Million | CN¥26.61 Million | ▲ +644.0% |
| 2006 | -0.13x | CN¥-7.39 Million | CN¥57.55 Million | CN¥64.95 Million | ▲ +81.9% |
| 2005 | -0.71x | CN¥-33.76 Million | CN¥47.48 Million | CN¥81.24 Million | ▼ -264.3% |
| 2004 | 0.43x | CN¥13.53 Million | CN¥31.26 Million | CN¥17.73 Million | ▼ -6.4% |
| 2003 | 0.46x | CN¥14.12 Million | CN¥30.55 Million | CN¥16.43 Million | — |